good numbers considering the short week. I like the NRx up 3% from previous week. On to 11K.
Good luck and God bless all Amarin investors.
Thanks Key for posting these numbers. Better than I expected for the holiday week (albeit a lesser holiday). We really need to see 11K next week.
Nice! Especially since this was a holiday week! Total down only 1.6%, while Lovaza was down 13.2% and Generic Lovaza was down 5.9%! And while both of the others were down big with new prescriptions, we were up 3.1%!! Thank you Keystone!
P.S. - Any chance you can look up the numbers for Auryxia from Keryx Pharmaceuticals? Nobody active on the boards for KERX seems to have access to the numbers. Thank you!
01/23/2015 SCRIPTS - (Vascepa surpasses Lovaza on NRx)
TR x: 9,879 (down 1.6% from 10,043 prior week)
NR x: 4,623 (up 3.1% from 4,483)
TR x:......15,098 (down 13.2% from 17,391)...............56,888 (down 5.9% from 60,429)
NR x: ....4,045 (down 12.5% from 4,624)....................25,520 (down 5.6% from 27,032)
Hopefully your parents had only one child....or the human gene pool will be in deep doodoo
There has most certainly been some unsavoury stuff; however, in hindsight, I wonder if some of the "writing was on the wall" after the Trilipix Adcom (around when MARINE was approved) which may have been the beginning of the reckoning for an outcomes study. AIM HIGH after that may have helped to reinforce the perception that drugs on top of statins don't help.
had to switch accounts cuz they're blocking me...must not like the truth I'm laying down.
Anyhow, watch the volume lately. The price is going nowhere but there's a constant stream of shares trading. I believe this is shares going from one bucket (Iong account) to the other (short cover). The Nasdaq numbers reflect this short exit, and I have a hunch we'll see a reduction in long shares in some of the hedgie's Holding companies when the Q4 13F's are filed.
So what’s next:
1. This is either a short reload where they're about to drop the rug on us again, re-short this downward as they buy the retail shake out. Or
2. they are reducing short float because they're about to turn this upward...again, picking up shares from weary retail who are happy to recover losses and get out.
We have seen 2 years of positioning. IMO this whole debacle has been orchestrated by BP, FDA and WS con artists to shake retail out of this stock. Just look at the Tut ownership increase while the price has dropped.
We're seeing 'the shorts' reduce exposure right now. They used end of year tax selling to shave 6M shares out of the short float (34M to 28M) in Q4 and have covered another million shares in the first 2 weeks of January on low volume.
In my opinion, we won’t see a short squeeze because of hedging. The same entities that are short are also long. This is the SEC's dirty little secret and why they don't require institutions to report short positions. Tuts use multiple accounts but they play both long and short algorithmically to manipulate price. This "promotes liquidity."
Why would they play a zero sum game like that? What's the point?
Well, they just drove AMRN down to $1. No loss because they'll zero balance between the Long and short positions when the price lands at their target. In this case, I believe the target was $1, and we’re seeing the short cover with the long shares they picked up on the way down.
What’s the point if they get it down here and don’t have a long position because they had to cover their short position with it? Think of how many here are just dying to get out of this stock at either a small loss or even? Who do you think will scoop up our shares as they start buying this back up through heavy resistance (weary retail) up to $2?
This is how the 'Tuts' build a position. They don't hype a stock and buy it up...they beat the junk out of it, create a bunch of panicked sellers who will irrationally hand the shares over at dumb prices at either a loss or break even.
The SPA rescission report is due by Feb 13. Any submission will likely be reviewed by professional staff shortly thereafter, and recommendations made to elected officials. Congress has the FDA lined up for public hearings very late Feb or early March (exact dates still TBD). We're doing our best to make sure that staff and Congressmen are well-briefed and have a list of questions to ask at the hearings to get to the bottom of this mess.
All true Kole. Really looking to NCE lawsuit and script growth due to Generic Lovaza's issue with Raising ldl-c higher than Lovaza and also Raising Trigs too!! Reps should be able to make a sea change in scripts very soon. NCE lawsuit looks very strong and if it goes to Amarin it will be a game changer for sure. These two will make a big difference in share price. What are you hearing about Congress and FDA?? Have heard some rumblings that Congress getting ready to tear into them. Is this true??
Sentiment: Strong Buy
Akanz2 is a fool.
You have all the time and willingness to share on yahoo until someone asks you to present any sort of proof that your story is not entirely made up and you think the person asking for proof is pulling something on you? Please explain.
Who couldn't figure out how to share actual proof they they are getting Vascepa "off label" for $9?
It is as if they think we are as stupid as they are.
WHAT ABOUT THIS ? -
Let's take a look for laughs:
Mar 12, 2013 - shortfishfry "Member since: Mar 12, 2013"
Mar 15, 2013 $8.46 - shortfishfry 3:16 PM, ".... buy, buy, buy!!!!"
May 29, 2013 $6.46 - shortfishfry 3:08 PM, " i don't see how the shorts can get out"
Jun 6, 2013 $6.64 - shortfishfry 10:22 AM, "I bought 4000 shares this morning at 6.65."
Jun 12, 2013 $6.81 - shortfishfry 4:09 PM, "This is a very good investment here IMO."
Jun 19, 2013 - $6.47 - shortfishfry 12:42 PM, "$6.5 seems like a safe entry."
Jun 25, 2013 $5.74 - shortfishfry 11:23 AM, "Initiated a position in my trading accnt at $5.65. Bought more at $5.45."
Jul 8, 2013 $6.17 - shortfishfry 5:31 PM, "I have my "All in" orders in place."
Jul 29, 2013 $5.38 -12:37 PM, shortfishfry, " I work as a senior process/business improvement consultant (six sigma master black belt) for a fortune 20 company so I know a thing or two about statistics and business analytics in general. .... As the executive decision maker on my own investments, I apply some of the same analytical techniques. "
Oct 17, 2013 $2.01 - 3:05 PM, shortfishfry, "I haven't lost a dime"
Oct 18, 2013 $2.03 - 6:08 PM, shortfishfry, "I not only didn't sell, I tripled up."
Nov 12, 2013 $1.54 - 6:17 PM, shortfishfry, "For this reason, I have averaged down nicely at current price."
Nov 15, 2013 $1.51
So, can a "six sigma master black belt" explain his buys and volume so that his posting claims can actually fit into reality? This ought to be great! Come on you piece of "six sigma" #$%$, tell us what is up with all of your pushing and pumping and lies?
Why have you been working so hard HERE m o t h e r f % $ @ # r?
While you have been here:
NOW - TODAY - $1.04 ???